Cerebras Systems (CBRS) shares surged more than 10% Monday morning after OpenAI CEO Sam Altman reaffirmed the artificial intelligence lab\u2019s partnership with the chipmaker, providing a boost to a stock that has faced pressure in recent months.<\/p>\n\n\n\n
\u201cCerebras is a close partner,\u201d Altman wrote on X, adding that the companies have a \u201cdeep engagement pushing on the frontiers of speed.\u201d<\/p>\n\n\n\n
The comments followed discussion surrounding OpenAI\u2019s GPT-5.6 Sol running in Ultrafast mode on Cerebras chips<\/strong>, as well as reported usage by quantitative trading firm Jane Street. The developments highlighted Cerebras\u2019 potential role in providing high-speed AI computing infrastructure as demand for faster inference continues to expand.<\/p>\n\n\n\n Cerebras shares traded around $181 Monday<\/strong>, extending gains after declining from their mid-August levels following disappointing earnings and guidance.<\/p>\n\n\n\n The company went public in May and is attempting to establish itself as a significant competitor in an AI accelerator market dominated by Nvidia. Cerebras is best known for its unusually large wafer-scale processors designed to accelerate demanding artificial intelligence workloads.<\/p>\n\n\n\n Altman\u2019s endorsement could strengthen investor confidence in Cerebras\u2019 technology and commercial positioning, particularly as OpenAI continues expanding its computing requirements.<\/p>\n\n\n\n With AI infrastructure spending accelerating, investors will now be watching whether Cerebras can translate high-profile partnerships into sustained revenue growth and improved financial performance.<\/p>\n","protected":false},"excerpt":{"rendered":" Shares surge more than 10% as OpenAI CEO highlights deep engagement with the AI chipmaker Cerebras Systems (CBRS) shares surged more than 10% Monday morning after OpenAI CEO Sam Altman reaffirmed the artificial intelligence lab\u2019s partnership with the chipmaker, providing a boost to a stock that has faced pressure in recent months. \u201cCerebras is a […]<\/p>\n","protected":false},"author":1,"featured_media":9428,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[]},"categories":[482,361],"tags":[1016,421,416,418,484,417],"coauthors":[453],"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/11273"}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=11273"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/11273\/revisions"}],"predecessor-version":[{"id":11274,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/11273\/revisions\/11274"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/9428"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=11273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=11273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=11273"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=11273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}